Recent News

521 News Items found
SKI Developmental Biology Program Chair Kat Hadjantonakis
The event featured scientific talks from leading women in science, including winners of this year’s Kravis WISE fellowships.
MSK molecular biologist Agnel Sfeir
Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021.
Developmental biologist Kathryn Anderson
Feature
Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute.
Roberta Zappasodi, Taha Merghoub, and Jedd Wolchok. Photo credit: Flynn Larsen for Ludwig Cancer Research
More sugar available for immune cells could mean better immune responses against cancer.
Scientists Jan Remsik, Adrienne Boire, and Jessica Wilcox in the lab
Finding
The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.
Hans-Guido Wendel
Originally explored as a cancer drug, the tree-derived chemical is now being mined for its antiviral properties.
Physician-scientist Alex Kentsis
In the Lab
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
Direna Alonso Curbelo
The insights lay the groundwork for earlier diagnosis and better treatment of the disease.
MSK immunologist Ming Li
Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
Francisco Sánchez-Rivera
During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.